UC Irvine MATRIX, a 7,700-square-foot biomanufacturing facility in Hewitt Hall on the main UC Irvine campus features advanced, state-of-the-art infrastructure optimized for biologics production. The facility incorporates segregated, controlled environments specifically designed for cell and viral vector manufacturing to support Phase I/II clinical trials. UC Irvine MATRIX provides best-in-class cGMP services including development of cGMP compliant processes and methods, manufacturing of cell and viral vector-based therapies, and release testing intended for early phase clinical trials.

Our facility provides advanced infrastructure and strict contamination controls. The operation is staffed by highly trained personnel and features a dedicated development area alongside seven ISO Class 7 manufacturing suites, each utilizing an independent HVAC system. Through cutting-edge engineering and operational excellence, we empower our partners to advance medical innovation and deliver potentially life-saving options directly to patients.